FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Astrid Van Hylckama Vlieg

Research Profile

Disorders

Concepts & Ideas

Procedures

Physiology

Genetic Predisposition to Disease

Chemicals & Drugs

Co-author Network

Publications

TOP 3
R E J Roach; Frits R Rosendaal; suzanne cannegieter; Frans M Helmerhorst; Willem M Lijfering; Astrid Van Hylckama Vlieg
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Sverre C Christiansen; Jens Hammerstrøm; Willem M Lijfering; Inger Anne Naess; Frits R Rosendaal; Astrid Van Hylckama Vlieg; suzanne cannegieter
The relationship between body mass index, activated protein C resistance and risk of venous thrombosis.
Kirsten van Langevelde; Linda E Flinterman; Frits R Rosendaal; Astrid Van Hylckama Vlieg; suzanne cannegieter
Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Astrid Van Hylckama Vlieg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: R E J Roach; Frits R Rosendaal; suzanne cannegieter; Frans M Helmerhorst; Willem M Lijfering; Astrid Van Hylckama Vlieg
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Journal of thrombosis and haemostasis : JTH 2013;11(1):124-31.
2012: Sverre C Christiansen; Jens Hammerstrøm; Willem M Lijfering; Inger Anne Naess; Frits R Rosendaal; Astrid Van Hylckama Vlieg; suzanne cannegieter
The relationship between body mass index, activated protein C resistance and risk of venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2012;10(9):1761-7.
2012: Kirsten van Langevelde; Linda E Flinterman; Frits R Rosendaal; Astrid Van Hylckama Vlieg; suzanne cannegieter
Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum.
Blood 2012;120(5):933-46.
2012: M J Engbers; Frits R Rosendaal; Mary Cushman; Astrid Van Hylckama Vlieg
The effect of time between venipuncture, processing and freezing on the measurement of coagulation factor levels.
Journal of thrombosis and haemostasis : JTH 2012;10(8):1691-3.
2012: D D Ribeiro; Frits R Rosendaal; Astrid Van Hylckama Vlieg; Willem M Lijfering; suzanne cannegieter
Pneumonia and risk of venous thrombosis: results from the MEGA study.
Journal of thrombosis and haemostasis : JTH 2012;10(6):1179-82.
2012: Linda Flinterman; suzanne cannegieter; Astrid Van Hylckama Vlieg; Frits R Rosendaal
Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors.
PLoS medicine 2012;9(1):e1001155.
2011: Marieke C H de Visser; Frits R Rosendaal; Sara Roshani; Julie W Rutten; Astrid Van Hylckama Vlieg; Hans L Vos; Pieter H Reitsma
Haplotypes of VKORC1, NQO1 and GGCX, their effect on activity levels of vitamin K-dependent coagulation factors, and the risk of venous thrombosis.
Thrombosis and haemostasis 2011;106(3):563-5.
2011: Astrid Van Hylckama Vlieg; Saskia Middeldorp
Hormone therapies and venous thromboembolism: where are we now?
Journal of thrombosis and haemostasis : JTH 2011;9(2):257-66.
2010: Astrid Van Hylckama Vlieg; Frans M Helmerhorst; Frits R Rosendaal
The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device.
Arteriosclerosis, thrombosis, and vascular biology 2010;30(11):2297-300.
2010: M J Engbers; Astrid Van Hylckama Vlieg; Frits R Rosendaal
Venous thrombosis in the elderly: incidence, risk factors and risk groups.
Journal of thrombosis and haemostasis : JTH 2010;8(10):2105-12.
2010: Linda Flinterman; Astrid Van Hylckama Vlieg; Frits R Rosendaal; C J M Doggen
Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk.
British journal of haematology 2010;149(1):118-23.
2010: L Heimans; Astrid Van Hylckama Vlieg; Friedo W Dekker
Are claims of advertisements in medical journals supported by RCTs?
The Netherlands journal of medicine 2010;68(1):46-9.
2009: Astrid Van Hylckama Vlieg; Frans M Helmerhorst; Jan P Vandenbroucke; C J M Doggen; Frits R Rosendaal
The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.
BMJ (Clinical research ed.) 2009;339():b2921.
2008: Saskia Middeldorp; Astrid Van Hylckama Vlieg
Does thrombophilia testing help in the clinical management of patients?
British journal of haematology 2008;143(3):321-35.
2008: Linda Flinterman; Astrid Van Hylckama Vlieg; Frits R Rosendaal; C J M Doggen
Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity.
Circulation 2008;118(13):1366-72.
2008: Astrid Van Hylckama Vlieg; C A Baglin; L A Bare; Frits R Rosendaal; T P Baglin
Proof of principle of potential clinical utility of multiple SNP analysis for prediction of recurrent venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2008;6(5):751-4.
2007: Astrid Van Hylckama Vlieg; Sverre C Christiansen; Roger Luddington; suzanne cannegieter; Frits R Rosendaal; T P Baglin
Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence.
British journal of haematology 2007;138(6):769-74.
2007: Frits R Rosendaal; Astrid Van Hylckama Vlieg; C J M Doggen
Venous thrombosis in the elderly.
Journal of thrombosis and haemostasis : JTH 2007;5 Suppl 1():310-7.
2007: Astrid Van Hylckama Vlieg; R Montes; Frits R Rosendaal; J Hermida
Autoantibodies against endothelial protein C receptor and the risk of a first deep vein thrombosis.
Journal of thrombosis and haemostasis : JTH 2007;5(7):1449-54.
2007: A Brandts; Astrid Van Hylckama Vlieg; Jan Rosing; T P Baglin; F R Rosendaal
The risk of venous thrombosis associated with a high endogenous thrombin potential in the absence and presence of activated protein C.
Journal of thrombosis and haemostasis : JTH 2007;5(2):416-8.
2006: C H Martini; A Brandts; E L E de Bruijne; Astrid Van Hylckama Vlieg; Frank W G Leebeek; Ton Lisman; Frits R Rosendaal
The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis.
British journal of haematology 2006;134(1):92-4.
2005: Nantarat Komanasin; Andrew J Catto; T Simon Futers; Astrid Van Hylckama Vlieg; Frits R Rosendaal; Robert A S Ariëns
A novel polymorphism in the factor XIII B-subunit (His95Arg): relationship to subunit dissociation and venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2005;3(11):2487-96.
2005: Astrid Van Hylckama Vlieg; C A Baglin; T P Baglin
Is there a true difference in recurrence rate of deep venous thrombosis between men and women?
Journal of thrombosis and haemostasis : JTH 2005;3(9):2113-4.
2005: Marieke C H de Visser; Astrid Van Hylckama Vlieg; Guido Tans; Jan Rosing; Anders Dahm; Per Morten Sandset; Frits R Rosendaal; Rogier M Bertina
Determinants of the APTT- and ETP-based APC sensitivity tests.
Journal of thrombosis and haemostasis : JTH 2005;3(7):1488-94.
2004: Astrid Van Hylckama Vlieg; Lodewijk A Sandkuijl; Frits R Rosendaal; Rogier M Bertina; Hans L Vos
Candidate gene approach in association studies: would the factor V Leiden mutation have been found by this approach?
European journal of human genetics : EJHG 2004;12(6):478-82.
2003: Astrid Van Hylckama Vlieg; Frits R Rosendaal
Interaction between oral contraceptive use and coagulation factor levels in deep venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2003;1(10):2186-90.
2003: Guido Tans; Astrid Van Hylckama Vlieg; M Christella L G D Thomassen; Joyce Curvers; Rogier M Bertina; Jan Rosing; Frits R Rosendaal
Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women.
British journal of haematology 2003;122(3):465-70.
2003: Frits R Rosendaal; Astrid Van Hylckama Vlieg; Bea C Tanis; Frans M Helmerhorst
Estrogens, progestogens and thrombosis.
Journal of thrombosis and haemostasis : JTH 2003;1(7):1371-80.
2003: Astrid Van Hylckama Vlieg; P W Callas; Mary Cushman; Rogier M Bertina; Frits R Rosendaal
Inter-relation of coagulation factors and d-dimer levels in healthy individuals.
Journal of thrombosis and haemostasis : JTH 2003;1(3):516-22.
2002: Astrid Van Hylckama Vlieg; Nantarat Komanasin; Robert A S Ariëns; swibertus rudolfus poort; Peter J Grant; Rogier M Bertina; Frits R Rosendaal
Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
British journal of haematology 2002;119(1):169-75.
2001: Huib Ceelie; Rogier M Bertina; Astrid Van Hylckama Vlieg; Frits R Rosendaal; Hans L Vos
Polymorphisms in the prothrombin gene and their association with plasma prothrombin levels.
Thrombosis and haemostasis 2001;85(6):1066-70.
2000: Astrid Van Hylckama Vlieg; Irma van der Linden; Rogier M Bertina; Frits R Rosendaal
High levels of factor IX increase the risk of venous thrombosis.
Blood 2000;95(12):3678-82.